Azelastine
Showing 1 - 25 of 62
Seasonal Allergic Rhinitis Trial in Toronto (Mometasone + Azelastine, Mometasone Furoate, Azelastine Hydrochloride)
Not yet recruiting
- Seasonal Allergic Rhinitis
- Mometasone + Azelastine
- +2 more
-
Toronto, Ontario, CanadaSandoz Investigational Site
May 24, 2023
Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A: Azelastine HCl 0.15% nasal spray (Azelair), Treatment B: Placebo
Recruiting
- Seasonal Allergic Rhinitis
- Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
- +2 more
-
Mississauga, Ontario, CanadaCliantha Research
Nov 6, 2023
Chronic Rhinitis Trial in Evanston (Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray, Mometasone
Not yet recruiting
- Chronic Rhinitis
- Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray
- +2 more
-
Evanston, IllinoisNorthshore University HealthSystem
Nov 30, 2022
Allergic Rhinitis Trial in Taichung, Tainan, Taipei (azelastine/fluticasone 137/50 mcg nasal spray, Dymista™)
Completed
- Allergic Rhinitis
- azelastine/fluticasone 137/50 mcg nasal spray
- Dymista™
-
Taichung, Taiwan
- +4 more
Sep 20, 2023
Seasonal Allergic Rhinitis Trial (Azelastine + Mometazone, nasal spray, Momat Rhino Advance)
Not yet recruiting
- Seasonal Allergic Rhinitis
- Azelastine + Mometazone, nasal spray
- Momat Rhino Advance
- (no location specified)
Dec 16, 2022
Allergic Rhinitis Trial in Cologne (Azelastine, Fluticasone, Azelastine mono, Azelastine)
Completed
- Allergic Rhinitis
- Azelastine, Fluticasone
- +2 more
-
Cologne, NRW, GermanyClinPharmCologne
Feb 4, 2022
Allergic Rhinitis Trial in Mississauga (Azelastine HCl (BAYR9258), Placebo)
Completed
- Allergic Rhinitis
- Azelastine hydrochloride (BAYR9258)
- Placebo
-
Mississauga, Ontario, CanadaCliantha Research
Mar 10, 2022
Allergic Rhinitis Trial in Cologne (Azelastine, Fluticasone, Fluticasone mono, Fluticasone)
Completed
- Allergic Rhinitis
- Azelastine, Fluticasone
- +2 more
-
Cologne, NRW, GermanyClinPharmCologne
Feb 4, 2022
Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A (Dymista): Fixed drug combination of azelastine HCl and fluticasone
Completed
- Seasonal Allergic Rhinitis
- Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3
- +3 more
-
Mississauga, Ontario, CanadaCliantha Research
Feb 11, 2022
Seasonal Allergic Rhinitis Trial in Mississauga (Azelastine HCl + fluticasone propionate nasal spray, Placebos, fluticasone
Completed
- Seasonal Allergic Rhinitis
- Azelastine hydrochloride + fluticasone propionate nasal spray
- +2 more
-
Mississauga, Ontario, CanadaInflamax Research
Feb 4, 2022
COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)
Active, not recruiting
- COVID-19
- Experimental: Primary Cohort
- Placebo Comparator: Primary Cohort - Placebo
-
Chicago, IllinoisUniversity of Chicago
Aug 24, 2023
Seasonal Allergic Rhinitis Trial in Sofia (Mometasone, Azelastine, Placebo)
Recruiting
- Seasonal Allergic Rhinitis
- Mometasone
- +2 more
-
Sofia, BulgariaSandoz Investigative Site
Apr 6, 2022
Seasonal Allergic Rhinitis Trial in Amman (140/100 µg Azelastine HCl/Beclomethasone Dipropionate))
Completed
- Seasonal Allergic Rhinitis
- 140/100 μg Azelastine hydrochloride/Beclomethasone Dipropionate)
-
Amman, JordanACDIMA Biocenter
Sep 15, 2021
Allergic Rhinitis Due to Allergens Trial in Izmir (AI201901, Azelastine Hydrochloride)
Recruiting
- Allergic Rhinitis Due to Allergens
- AI201901
- Azelastine Hydrochloride
-
Izmir, TurkeyDokuz Eylul University
May 17, 2022
Allergic Rhinitis Trial in Wuhan (Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray,
Not yet recruiting
- Allergic Rhinitis
- Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray
- Fluticasone Nasal 50 Mcg/Inh Nasal Spray
-
Wuhan, Hubei, ChinaTongji Hosptial affiliated to Tongji Medical college of Huazhong
Dec 4, 2022
Allergic Rhinitis Trial in Shiraz (Montelukast, Azelastine, Budesonide)
Unknown status
- Allergic Rhinitis
- Montelukast
- +3 more
-
Shiraz, Iran, Islamic Republic ofShiraz University of Medical Science
Sep 23, 2020
Allergic Rhinitis Trial in China (Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT, Azelastine Hydrochloride 0.137
Completed
- Allergic Rhinitis
- Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT
- +2 more
-
Beijing, Beijing, China
- +32 more
Feb 4, 2022
Allergic Rhinitis Trial (Fluticasone Propionate, Azelastine HCl and fluticasone propionate, Rupatadine)
Unknown status
- Allergic Rhinitis
- Fluticasone Propionate
- +2 more
- (no location specified)
Oct 22, 2020
Seasonal Allergic Rhinitis Trial in United States (Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray, Placebo nasal
Completed
- Seasonal Allergic Rhinitis
- Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray
- Placebo nasal spray
-
Stockbridge, Georgia
- +29 more
Oct 20, 2021
Allergic Rhinitis Trial in Den Haag (Acupuncture, Antihistamine nasal spray)
Not yet recruiting
- Allergic Rhinitis
- Acupuncture
- Antihistamine nasal spray
-
Den Haag, Zuid-Holland, NetherlandsMermaid Medicine®
Feb 1, 2023
Asthma, Allergic, Rhinitis,Allergic, Allergy Trial in Dundee (Azelastine-Fluticasone Nasal, Placebos)
Terminated
- Asthma, Allergic
- +2 more
- Azelastine-Fluticasone Nasal
- Placebos
-
Dundee, Scotland, United KingdomScottish Centre for Respiratory Research, University of Dundee,
Apr 4, 2019
Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes
Withdrawn
- Allergic Rhinitis
- Observational
-
Sydney, New South Wales, AustraliaCommunity and Patient Preference Research Pty Ltd
Mar 29, 2022
Patient Satisfaction and Sensory Attributes Allergic Rhinitis
Completed
- Allergic Rhinitis
- Observational
-
Sydney, New South Wales, AustraliaCommunity and Patient Preference Research Pty Ltd
Jun 29, 2022
Allergy Trial in Vienna (Blood sampling, Nasal biopsies, Nasal specimen collection)
Recruiting
- Allergy
- Blood sampling
- +7 more
-
Vienna, AustriaMedical University of Vienna
Nov 14, 2021